Skip to main content

Table 1 Characteristics of patients ventilated for ≥ 4 consecutive days

From: Incidence and clinical outcomes of ventilator-associated events in Russian tertiary care settings: an analysis of electronic health records

Characteristic

Overall,

N = 269

VAE-plus,

N = 35

VAE-minus,

N = 234

Age, mean (SD)

64 (17)

62 (17)

64 (17)

Sex, male

147 (55%)

18 (51%)

129 (55%)

Primary pathology

Neoplasms or hematological diseases

72 (26.8%)

7 (20.0%)

65 (27.8%)

Diseases of the circulatory system

65 (24.2%)

8 (22.9%)

57 (24.3%)

Diseases of the respiratory system

35 (13.0%)

6 (17.1%)

29 (12.4%)

Diseases of the digestive system

33 (12.2%)

5 (14.3%)

28 (12.0%)

Injury, poisoning and external causes

26 (9.7%)

4 (11.4%)

22 (9.4%)

Other

38 (14.1%)

5 (14.3%)

33 (14.1%)

Comorbidities

Congestive heart failure

106 (39.4%)

8 (22.9%)

98 (41.9%)

Localized tumor

60 (22.3%)

10 (28.6%)

50 (21.4%)

Metastatic cancer

35 (13.0%)

6 (17.1%)

29 (12.4%)

Hematological malignancy

30 (11.2%)

6 (17.1%)

24 (10.3%)

COPD

23 (8.6%)

3 (8.6%)

20 (8.5%)

Clinical scores and events at ICU admission

SOFA, median (IQR)

7.0 (4.0, 9.0)

9.0 (4.0, 10.0)

7.0 (4.0, 9.0)

CCI, median (IQR)

6.0 (3.0, 9.0)

6.0 (2.0, 8.0)

6.0 (3.0, 9.0)

Major surgery

128 (47.6%)

21 (60%)

107 (45.7%)

Primary reason for MV initiation

Respiratory failure

113 (42.0%)

10 (28.6%)

103 (44.0%)

Neurological deterioration

84 (31.2%)

14 (40.0%)

70 (29.9%)

General anesthesia

52 (19.3%)

11 (31.4%)

41 (17.5%)

CPR

20 (7.5%)

-

20 (8.5%)

  1. Abbreviations: VAE, ventilator-associated event; SD, standard deviation; IQR, interquartile range; SOFA, Sequential Organ Failure Assessment score; CCI, Charlson Comorbidity Index; COPD, chronic pulmonary obstructive disease; CPR, cardiopulmonary resuscitation; N, number
  2. Categories: VAE-plus, patients who developed VAE; VAE-minus, patients who did not develop VAE